Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Therapy”

2,734 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,734 results

Not applicableNot Yet RecruitingNCT07083349
What this trial is testing

NK510 Cell Therapy for Refractory Systemic Lupus Erythematosus

Who this might be right for
Refractory Systemic Lupus Erythematosus
Base Therapeutics (Shanghai) Co., Ltd. 9
Large-scale testing (Phase 3)Study completedNCT00144612
What this trial is testing

Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Chugai Pharmaceutical 60
Not applicableStudy completedNCT06093360
What this trial is testing

Flapless Surgical Treatment of Peri-implantitis

Who this might be right for
Peri-Implantitis
Universidad Complutense de Madrid 117
Large-scale testing (Phase 3)Study completedNCT00001810
What this trial is testing

An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections

Who this might be right for
AspergillosisCandidiasisFungemia+1 more
National Cancer Institute (NCI) 300
Early research (Phase 1)Looking for participantsNCT06349343
What this trial is testing

CD19/BCMA CAR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 20
Large-scale testing (Phase 3)Looking for participantsNCT06561048
What this trial is testing

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

Who this might be right for
Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T-cell LymphomaFollicular T-Cell Lymphoma+4 more
Corvus Pharmaceuticals, Inc. 150
Not applicableUnknownNCT04127968
What this trial is testing

Efficacy and Safety of Vitamin A Treatment for Children With Sepsis

Who this might be right for
Vitamin A DeficiencyPediatricSepsis
West China Hospital 450
Large-scale testing (Phase 3)Ended earlyNCT00174291
What this trial is testing

Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy

Who this might be right for
Endocrine System Diseases
Pfizer 21
Post-approval studies (Phase 4)WithdrawnNCT05355350
What this trial is testing

PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections

Who this might be right for
Beta Lactam Resistant Bacterial InfectionEnterobacteriaceae InfectionsBacteremia
Rambam Health Care Campus
Testing effectiveness (Phase 2)UnknownNCT03752489
What this trial is testing

Unsupervised Machine Learning for Clustering of Septic Patients to Determine Optimal Treatment

Who this might be right for
SepsisSevere SepsisSeptic Shock
Dascena 51,645
Early research (Phase 1)Ended earlyNCT00479622
What this trial is testing

Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Wyeth is now a wholly owned subsidiary of Pfizer 20
Not applicableLooking for participantsNCT05634057
What this trial is testing

Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis

Who this might be right for
Sepsis
Chen Ying 782
Testing effectiveness (Phase 2)Study completedNCT00423098
What this trial is testing

Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 81
Not applicableLooking for participantsNCT06284343
What this trial is testing

The Gynecological Cancer Associated Thrombosis (GynCAT) Study

Who this might be right for
Cancer-associated ThrombosisVenous ThromboembolismGynecologic Cancer+4 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1,800
Not applicableStudy completedNCT01215825
What this trial is testing

The Doses of Systemic Steroid in Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Far Eastern Memorial Hospital 164
Post-approval studies (Phase 4)Study completedNCT00307671
What this trial is testing

Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years

Who this might be right for
VasculitisWegener's GranulomatosisMicroscopic Polyangiitis+2 more
Assistance Publique - Hôpitaux de Paris 108
Post-approval studies (Phase 4)Study completedNCT01450358
What this trial is testing

Evaluation in the Treatment of Nosocomial Sepsis Comparing Polymerase Chain Reaction With Conventional Blood Culture.

Who this might be right for
SepsisBacteremiaFungemia
Instituto do Coracao 200
Testing effectiveness (Phase 2)Ended earlyNCT02949947
What this trial is testing

Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic Therapy

Who this might be right for
Malignant Neoplasms of Mesothelial and Soft TissueGastrointestinal Stromal Tumor With Neurogenic Differentiation
M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07236463
What this trial is testing

Labile Iron Removal by Adding the Iron Chelator MEX-CD1 to Dialysate in Sepsis-Associated Acute Kidney Injury

Who this might be right for
Acute Kidney InjurySepsis
Centre Hospitalier Universitaire de Nīmes 14
Testing effectiveness (Phase 2)WithdrawnNCT05567406
What this trial is testing

Safety and Efficacy of Oral Belumosudil in Black or African American, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander Male and Female Participants Aged 12 Years and Above With Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy

Who this might be right for
Chronic Graft Versus Host Disease
Kadmon, a Sanofi Company
Load More Results